Skip to content

Liquid chromatography-electrospray mass spectrometry determination of ibogaine and noribogaine in human plasma and whole blood. Application to a poisoning involving Tabernanthe iboga root.

Violeta Kontrimaviciūte, Hélène Breton, Olivier Mathieu, Jean-Claude Mathieu-Daudé, Françoise M M Bressolle

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences November 7, 2006 DOI: 10.1016/j.jchromb.2006.05.035 via PubMed

Summary

AI-generated from the abstract

A new laboratory method using liquid chromatography and mass spectrometry was developed to measure ibogaine and noribogaine in human plasma and whole blood. The method extracts the compounds from samples, separates them on a column, and detects them by their mass-to-charge ratios. It accurately quantifies ibogaine and noribogaine across a range of concentrations, with high precision and recovery. The drugs remain stable in frozen plasma for at least one year and in blood for up to two months at -20 degrees Celsius. The method was successfully applied to analyze a poisoning case involving Tabernanthe iboga root.

Study at a glance

Characteristics Method development and validation Peer reviewed
Population Human plasma and whole blood
Keywords Ibogaine quantification Noribogaine measurement Clinical toxicology Poisoning analysis Bioanalytical methods
Citations 27
Key finding A validated LC-ESI-MS method was developed for quantifying ibogaine and noribogaine in human plasma and whole blood, and applied to a poisoning case.

Abstract

A liquid chromatography/electrospray ionization mass spectrometry (LC-ESI-MS) method was developed for the first time for the determination of ibogaine and noribogaine in human plasma and whole blood. The method involved solid phase extraction of the compounds and the internal standard (fluorescein) from the two matrices using OasisHLB columns. LC separation was performed on a Zorbax eclipse XD8 C8 column (5 microm) with a mobile phase of acetonitrile containing 0.02% (v/v) trimethylamine and 2mM ammonium formate buffer. MS data were acquired in single ion monitoring mode at m/z 311.2, 297.2 and 332.5 for ibogaine, noribogaine and fluorescein, respectively. The drug/internal standard peak area ratios were linked via a quadratic relationship to plasma (0.89-179 microg/l for ibogaine; 1-200 microg/l for noribogaine) and to whole blood concentrations (1.78-358 microg/kg for ibogaine; 2-400 microg/kg for noribogaine). Precision ranged from 4.5 to 13% and accuracy was 89-102%. Dilution of the samples had no influence on the performance of the method. Extraction recoveries were > or =94% in plasma and > or =57% in whole blood. The lower limits of quantitation were 0.89 microg/l for ibogaine and 1 microg/l for noribogaine in plasma, and 1.78 microg/kg for ibogaine and 2 microg/kg for noribogaine in whole blood. In frozen plasma samples, the two drugs were stable for at least 1 year. In blood, ibogaine and noribogaine were stable for 4h at 4 degrees C and 20 degrees C and 2 months at -20 degrees C. The method was successfully used for the analysis of a poisoning involving Tabernanthe iboga root.

Comments

No comments yet.

Log in to comment